This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Source-linked GALP Western blot protocol options, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-GALP WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, source-linked protocol options, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~12.5 kDa | |
| Observed band | ~15, 18 kDa | |
| Gel | 5–20% (catalog A04786-1) | |
| Negative control | Suggested KO / knockdown lysate |
| PTM | Cleaved | |
| Caveat | Processing-state controls | |
| Gene-set association | MSigDB C7 membership | |
| Isoform | 2 isoform(s) |
The A04786-1 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | human SH-SY5Y, human placenta, rat brain, rat liver, rat C6, mouse brain, mouse liver (catalog A04786-1) |
| Gel % | 5–20% (catalog A04786-1) |
| Load | 30 ug; reducing conditions (catalog A04786-1) |
| Transfer | a nitrocellulose membrane at 150 mA for 50-90 minutes (catalog A04786-1) |
| Membrane | nitrocellulose membrane (catalog A04786-1) |
| Blocking | 5% non-fat milk/TBS for 1.5 hour at RT (catalog A04786-1) |
| Primary antibody | A04786-1 · 0.25 μg/mL (catalog A04786-1) |
| Primary incubation | overnight at 4°C (catalog A04786-1) |
| Secondary antibody | goat anti-rabbit IgG-HRP, 1:5000 (catalog A04786-1) |
| Secondary incubation | 1.5 hour at RT (catalog A04786-1) |
| Wash | TBS-0.1%Tween 3 times with 5 minutes each (catalog A04786-1) |
| Detection | ECL (catalog A04786-1) |
GALP is predicted at 12.5 kDa; empirical bands occur near 15 and 18 kDa, and the cause of that difference is not established.
| Bands near 15 and 18 kDa | Empirical GALP antibody signals; their identities require confirmation |
| Band near 12.5 kDa | Compatible with the predicted precursor mass |
| Band below the precursor size | Could reflect signal peptide or propeptide cleavage |
| Little or no band in whole-cell lysate | GALP is secreted |
| Multiple bands | Isoforms 1 and 2 or processing are possible, but distinct migration is unproven |
| Predicted precursor mass | 12.5 kDa is the sequence-based reference; empirical bands occur near 15 and 18 kDa for unestablished reasons |
| Signal peptide at residues 1–24 | Cleavage can yield a smaller product than the precursor |
| Propeptide at residues 87–116 | Cleavage can yield a smaller product than the precursor |
| Splice isoforms 1 and 2 | Sequence differences may affect size, but relative masses and distinct migration are not supplied |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | Secreted GALP may be scarce in the cell fraction | Check conditioned medium or an appropriate secreted-protein fraction |
| Band higher than expected | The cause of the reported 15 and 18 kDa signals relative to 12.5 kDa is unestablished | Check the size marker and validate band identity with an independent antibody or GALP depletion |
| Band lower than expected | Signal peptide or propeptide cleavage may produce smaller GALP species | Compare antibodies against retained and cleaved regions |
| Multiple bands | Isoforms or processing are possible, but neither is assigned to the observed bands | Test band identity with GALP depletion and region-specific antibodies |
| Weak or no signal | Secreted GALP may be low in the tested fraction | Check sample fraction and include a validated positive control |
| Fragments below expected size | GALP is a processed peptide precursor | Check epitope location and compare freshly prepared samples with protease-protected samples |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| No high/medium HPA tissues identified in the supplied evidence. | ||||
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| No lower-expression tissue rows available in the supplied evidence. | ||||
Deeper troubleshooting and optimisation questions for GALP, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
the supplier A04786-1 has a Western blot image using human, rat, and mouse cell or tissue lysates. The caption reports GALP bands near 15 and 18 kDa, compared with an expected 13 kDa; these examples do not establish performance in every sample.
Which to pick: A04786-1 is the only listed option. Its stated reactivity is human, mouse, and rat, and its Western blot image includes samples from each. Check the reported 15 and 18 kDa bands against the expected 13 kDa when interpreting results.